Li, Youxian
Watanabe, Eiichiro http://orcid.org/0000-0003-2050-3740
Kawashima, Yusuke http://orcid.org/0000-0002-9779-8199
Plichta, Damian R. http://orcid.org/0000-0002-6555-2557
Wang, Zhujun
Ujike, Makoto http://orcid.org/0000-0002-7145-7126
Ang, Qi Yan http://orcid.org/0000-0002-9788-1283
Wu, Runrun
Furuichi, Munehiro http://orcid.org/0000-0001-7742-1135
Takeshita, Kozue
Yoshida, Koji http://orcid.org/0000-0002-0466-8994
Nishiyama, Keita
Kearney, Sean M.
Suda, Wataru
Hattori, Masahira
Sasajima, Satoshi
Matsunaga, Takahiro
Zhang, Xiaoxi
Watanabe, Kazuto
Fujishiro, Jun
Norman, Jason M. http://orcid.org/0000-0001-5049-8415
Olle, Bernat
Matsuyama, Shutoku
Namkoong, Ho
Uwamino, Yoshifumi
Ishii, Makoto
Fukunaga, Koichi
Hasegawa, Naoki http://orcid.org/0000-0003-0717-7450
Ohara, Osamu http://orcid.org/0000-0002-3328-9571
Xavier, Ramnik J. http://orcid.org/0000-0002-5630-5167
Atarashi, Koji http://orcid.org/0000-0001-5422-0736
Honda, Kenya http://orcid.org/0000-0001-8937-9835
Article History
Received: 1 August 2021
Accepted: 2 August 2022
First Online: 7 September 2022
Competing interests
: K.H. is a scientific advisory board member of Vedanta Biosciences and 4BIO CAPITAL. K.W. is an employee of JSR corporation. J.M.N. and B.O. are employees of Vedanta Biosciences. R.J.X. is co-founder of Celsius Therapeutics and Jnana Therapeutics & SAB member, Senda Biosciences and Nestle. The other authors declare no competing interests.